Age-related macular degeneration (AMD) is a common condition involving damage to the macular, which affects central vision.AMD commonly affects people in their 50s -60s.
Visual distortions, such as straight lines seeming bent.
Reduced central vision in one or both eyes.
The need for brighter light when reading or doing close-up work.
Increased difficulty adapting to low light levels, such as when entering a dimly lit restaurant.
Increased blurriness of printed words.
Causes and risk factors
Exact macular degeneration causes are unknown, although there is evidence that certain people are at a higher risk of developing AMD. These include smokers, overweight individuals, those with high blood pressure, and people with a family history of age-related macular degeneration.
Dr Ankita Patil Eye specialist will discuss your personalised treatment programme with you.
The majority of people with wet AMD only require these injections several times a year.
Ranibizumab (also called the brand name Lucentis) or Aflibercept (also called the brand name Eylea). These are anti-VEGF medicines which prevent abnormal vessels from growing, leaking and bleeding under the retina.
Photodynamic therapy (PDT), where a light is shined to the back of the eye in order to destroy abnormal blood vessels
Unfortunately, there is currently no treatment options available for dry ARMD, but vision aids and practical support will be given to minimise impact on your day-to-day life.